ROGER RUTLEDGE: Open Payments
NPI 1467487728 · WEST MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,006 in 50 payments from 19 companies in 2025. Trend: 2023 $1,934 · 2024 $856 · 2025 $1,006
Food & beverage: $1,006
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $156 |
| ABBVIE INC. | 6 | $114 |
| Novo Nordisk Inc | 5 | $96 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $94 |
| Abbott Laboratories | 4 | $81 |
| PFIZER INC. | 4 | $80 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Lilly USA, LLC | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Antares Pharma, Inc. | 1 | $37 |
Products named: FARXIGA, CAPLYTA, FREESTYLE LIBRE 3, Rybelsus, JARDIANCE, UBRELVY, Auvelity, NURTEC ODT.
Industry payments across LA — which companies pay providers there.
